{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-000789","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.994503+00:00","generated_at":"2026-05-16T04:23:08.856691+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Sunshine Biopharma COO Dr. Abderrazzak Merzouki resigns effective immediately","bullets":["Dr. Abderrazzak Merzouki resigned as COO of Sunshine Biopharma on February 5, 2026, effective immediately.","No replacement or interim COO has been announced in the filing.","The resignation is reported under Item 5.02 with no stated reason for departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-000789","json":"https://secwatch.observer/filing/0001683168-26-000789.json","markdown":"https://secwatch.observer/filing/0001683168-26-000789.md","text":"https://secwatch.observer/filing/0001683168-26-000789.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826000789/0001683168-26-000789-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826000789/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:23:08.856691+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}